October 18-20 | Tucson, AZ

The Research Institution GAP Fund and Accelerator Program Summit

Visit Event Site

Monash University biotech spinout Rage lands $29 million Series A

GET GAP Insights

Join Us

October 16-17, 2025 / Seattle, WA

The annual summit for research institution gap fund and accelerator programs, including proof of concept programs, startup accelerators, and university venture funds

Visit event site

The Story

The round was led by IP Group Australia and super fund Hostplus, with support from existing investors including Monash Ventures. The funds will go towards first-in-human clinical trials for Rage’s nasal therapy to treat inflammatory lung diseases

The startup’s name is an acronym of Receptor for Advanced Glycation End-products (RAGE), a receptor involved in inflammation in chronic lung diseases and other conditions.

Rage Bio was founded as a spinout between IP Group Australia and Monash, Murdoch and WA universities and the and the Baker and Perron medical research institutes, to develop technology and treatments for inflammatory disorders.

 

Full story: University biotech spinout Rage lands $29 million Series A – Startup Daily

JOIN THE COMMUNITY

Get the Report

More GAP News

Consortium For Gap Fund and Accelerator ProgramS

Explore Institutional Participation

The Consortium provides a dedicated, institutional coordinating forum for collective insight, program refinement, and structured engagement with aligned commercial, investment, and philanthropic partners.

GAP are an interdependent institutional innovation and capital strategy that includes:

  • Translational research

  • Proof of concept programs

  • Startup accelerators

  • University venture funds

Get GAP Insights